Femto Medicine - Part 1149

Page 1,149«..10 20..1,1481,1491,150 1,151..1,160 1,170..»

Aspirin Not Protective Against CVD in Black Patients – TCTMD

Posted: Published on December 25th, 2019

Black patients are less likely than white patients to take low-dose aspirin for primary prevention of cardiovascular disease, observational data on more than 65,000 people show. As has previously been shown in earlier studies focused on different populations, though, aspirin didnt appear to have a protective effect in black individuals. The drug was once the mainstay of preventive regimens for CVD Continue reading →

Posted in Clinical Cardiology | Comments Off

Far From Home: No Easy Answers | WNIJ and WNIU – WNIJ and WNIU

Posted: Published on December 24th, 2019

In the 2017-18 school year, Illinois taxpayers funded the placement of close to 350 special education students at some 40 facilities in other states. Those facilities were as varied as the students needs Continue reading →

Posted in Brain Injury Treatment | Comments Off

Does Russell Wilson Really Believe This Water Prevents Concussions? – Sportscasting

Posted: Published on December 24th, 2019

The NFL takes concussions more seriously than ever. Continue reading →

Posted in Brain Injury Treatment | Comments Off

Neuroprotection Market Estimated to Flourish by 2025 – Market Research Sheets

Posted: Published on December 24th, 2019

Theglobal neuroprotection marketwas valued at approximately US$ 47,000.0 Mn in 2016 is projected to register a growth rate of 8.2% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled Neuroprotection Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20172025. Continue reading →

Posted in Brain Injury Treatment | Comments Off

Powering Precision Health Summit Convenes the World’s Most Renowned Scientific Innovators Advancing Biomarker Technologies – Business Wire

Posted: Published on December 24th, 2019

BILLERICA, Mass.--(BUSINESS WIRE)--Powering Precision Health (PPH), the internationally acclaimed Summit focused on precision health and the latest in biomarker research, drew record attendance at its fourth-annual event held Nov. 19 in Barcelona, Spain, convening the worlds foremost scientists and medical leaders in precision health to introduce novel and disruptive research across the fields of neurology and oncology. The PPH Summit continues to evolve and grow as the global epicenter for transforming healthcare with the use of non-invasive biochemical biomarkers, and this years event was no exception, said Kevin Hrusovsky, PPH Founder. Continue reading →

Posted in Brain Injury Treatment | Comments Off

List of Amyotrophic Lateral Sclerosis Medications (5 Compared …

Posted: Published on December 23rd, 2019

Other names: ALS; Lou Gehrig's Disease; Motor Neurone Disease About Amyotrophic Lateral Sclerosis: A disease of the motor nerve cells in the brain and spinal cord, causing progressive loss of motor control. Continue reading →

Posted in ALS Treatment | Comments Off

RADICAVA (edaravone)

Posted: Published on December 23rd, 2019

I agree that I have read this Consent Form and by providing my personal information and clicking SIGN UP FOR UPDATES I understand and agree that Mitsubishi Tanabe Pharma America, Inc. Continue reading →

Posted in ALS Treatment | Comments Off

Amylyx Pharmaceuticals Announces AMX0035 Demonstrated Statistically Significant Treatment Benefit for People with ALS in the CENTAUR Trial – Business…

Posted: Published on December 23rd, 2019

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, and the Sean M. Healey & AMG Center for ALS at Mass General today announced that AMX0035 demonstrated a significant treatment benefit for people with ALS in the CENTAUR study. In the study, participants taking AMX0035 had a statistically significant slowing of ALS disease progression as measured by the ALS Functional Rating Scale-Revised (ALSFRS-R) compared to placebo (p Continue reading →

Posted in ALS Treatment | Comments Off

Christmas in the City thrills homeless families, takes on poignancy with founders ALS diagnosis – The Boston Globe

Posted: Published on December 23rd, 2019

Wow, its beautiful! said Aylajoy Dufresne, 5, who wore a pink tutu, as she ran to princess Elena of Avalor and hugged her. Elena! I wasnt expecting all this, said her mother, Cassy Dufresne. Continue reading →

Posted in ALS Treatment | Comments Off

AB Science announces the publication of new results in the peer-reviewed journal Glia that further support masitinib’s potential mode of action in ALS…

Posted: Published on December 23rd, 2019

December 23, 2019 02:11 ET | Source: AB Science multilang-release Paris, 23 December 2019, 8.15am New results published in the peer-reviewed journal Glia further support masitinibs potential mode of action in ALS AB Science SA (NYSE Euronext - FR0010557264 - AB) today announced the publication by an international team of researchers of a previously unknown mechanism linked to the progression of Amyotrophic Lateral Sclerosis (ALS) that further reinforces the rationale for masitinibs potential neuroprotective effect in ALS. The publication, led by researchers from the Institut Pasteur de Montevideo, the University of Alabama at Birmingham (UAB), the Oregon State University (OSU) and the IMAGINE Institute of Paris, is entitled, Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL34, and SCF in amyotrophic lateral sclerosis. Continue reading →

Posted in ALS Treatment | Comments Off

Page 1,149«..10 20..1,1481,1491,150 1,151..1,160 1,170..»